Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04253561 |
|---|---|
| Brief Title: | Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients (IPATHER) |
| First Submitted : | January 17, 2020 |
| First Submitted that Met QC Criteria : | January 30, 2020 |
| First Posted : | February 5, 2020 |
| Last Update Submitted that Met QC Criteria : | April 17, 2023 |
| Last Update Posted : | April 18, 2023 |